Feb 24, 2019 - If you liked Exact Sciences' latest quarterly results, you'll probably love what could be in store.
Feb 26, 2019 - Top drug companies addressed sky-high drug prices on Capitol Hill today.
Mar 04, 2019 - Pfizer and Alnylam have a fierce, young contender with a chance to catch up in a big way.
Mar 13, 2019 - Lilly's (LLY) cancer drug, Cyramza, in combination with erlotinib significantly delays disease progression in a phase III study on previously untreated patients with EGFR-mutated metastatic NSCLC.
Mar 13, 2019 - Aerie (AERI) gets FDA approval for Rocklatan to reduce elevated IOP in patients with open-angle glaucoma or ocular hypertension and announces its 2019 revenue and cash burn outlook.
Mar 15, 2019 - Regulatory updates from J&J (JNJ), Merck (MRK), Roche (RHHBY), Pfizer (PFE) and others.
Mar 19, 2019 - The FDA approves Allergan's (AGN) sNDA for the label expansion of its antibacterial medicine, Avycaz, to treat cUTI and cIAI in pediatric patients.
Mar 19, 2019 - Aerie (AERI) begins dosing in a phase II study on AR-1105 for treating patients with macular edema due to retinal vein occlusion.
Mar 22, 2019 - Aerie (AERI) begins dosing in a phase II study on netarsudil ophthalmic solution in Japan for curbing high intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Shares Up.
Apr 03, 2019 - Top Research Reports for Pfizer, Royal Dutch Shell & Celgene